FDA
Pharma

More transparency, evidence needed for accelerated nods: ICER

The FDA should strengthen the evidence required for accelerated drug approvals and increase transparency surrounding those decisions, ICER says.
Kevin Dunleavy Apr 17, 2026 11:22am
law and order concept

In Lilly patent spat, appeals court revives $177M verdict to Teva

Apr 17, 2026 10:16am
Asia

Astellas, GSK-Hansoh, Daiichi—Fierce Pharma Asia

Apr 17, 2026 9:15am
American flag red white and blue

BIO comes out swinging with 'Fight of Our Lives' campaign

Apr 17, 2026 6:17am
Verily Me health app image

Verily helps patients 'Make it Make Sense' in new campaign

Apr 16, 2026 3:52pm
Food and Drug Administration

Regulatory tracker: GSK's Blenrep gets all-clear in NICE guidance

Apr 16, 2026 2:00pm
More News

Anti-amyloid Alzheimer's drugs show 'trivial' effects: report

Apr 16, 2026 11:36am

Roche to launch another Elevidys study, eying EU approval

Apr 16, 2026 10:06am

Lilly answers FDA's call for more Foundayo safety information

Apr 16, 2026 9:43am

Omnicom brews Olixir from FCB Health, rebranding storied agency

Apr 16, 2026 8:01am